{
  "symbol": "MDCX",
  "company_name": "Medicus Pharma Ltd",
  "ir_website": "https://medicuspharma.com/investor-relations/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Medicus Pharma Announces New Partnership",
          "url": "https://medicuspharma.com/investor-relations/press-releases/#partnership",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\nPress Releases\n\n#### News\n\n  * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n  * [Videos](https://medicuspharma.com/videos/)\n  * [Events](https://medicuspharma.com/events/)\n  * [Media](https://medicuspharma.com/media/)\n\n\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Q2 2024 Financial Report",
          "url": "https://medicuspharma.com/investor-relations/financial-reports/#Q2_2024",
          "content": "[![Medicus Pharma Logo](https://medicuspharma.com/wp-content/uploads/2023/10/medicus-logo.png)](/)\n\n  * [About](https://medicuspharma.com/about-us/)\n  * [Team](https://medicuspharma.com/team/)\n  * [Portfolio Companies](https://medicuspharma.com/portfolio-companies/)\n  * [News & Events](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Videos](https://medicuspharma.com/videos/)\n    * [Events](https://medicuspharma.com/events/)\n    * [Media](https://medicuspharma.com/media/)\n  * [Investor Relations](https://medicuspharma.com/investor-relations/)\n    * [Overview](https://medicuspharma.com/investor-relations/)\n    * [Press Releases](https://medicuspharma.com/investor-relations/press-releases/)\n    * [Events & Presentations](https://medicuspharma.com/investor-relations/presentations/)\n    * [Stock Data](https://medicuspharma.com/investor-relations/stock-data/)\n    * [Team](https://medicuspharma.com/team/)\n    * [Corporate Govenance](https://medicuspharma.com/corporate-govenance/)\n    * [SEDAR Filings](https://www.sedarplus.ca/landingpage/)\n    * [Email Alerts](https://medicuspharma.com/investor-relations/email-alerts/)\n  * [Contact](https://medicuspharma.com/investor-relations/contact/)\n\n\n\n# No Results Found\n\nThe page you requested could not be found. Try refining your search, or use the navigation above to locate the post.\n\nSearch\n\nSearch\n\n## Recent Posts\n\n  * [Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region](https://medicuspharma.com/medicus-pharma-ltd-announces-collaboration-agreement-to-expand-phase-2-clinical-study-in-asia-pacific-region/)\n  * [Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer](https://medicuspharma.com/medicus-pharma-ltd-appoints-faisal-mehmud-md-mrcp-as-chief-medical-officer/)\n  * [Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-closing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States](https://medicuspharma.com/medicus-pharma-ltd-announces-pricing-of-us4-0m-initial-public-offering-in-the-united-states/)\n  * [Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing](https://medicuspharma.com/medicus-pharma-ltd-announces-share-consolidation-in-anticipation-of-proposed-u-s-listing/)\n\n\n\n## Recent Comments\n\nNo comments to show.\n"
        }
      ]
    }
  ]
}